Zobrazeno 1 - 10
of 73
pro vyhledávání: '"G. V. Matyushin"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 1, Pp 77-82 (2023)
Mitral valve prolapse (MVP) has long been the subject of intense discussions regarding the prognosis and follow-up tactics. In most cases, this condition has a benign prognosis. However, recent autopsy and follow-up studies have shown risks of develo
Externí odkaz:
https://doaj.org/article/adb52e6aa195495093af8e37eb7d0e06
Autor:
O. O. Kuznetsova, S. Yu. Nikulina, G. V. Matyushin, A. A. Chernova, V. A. Sakovich, V. N. Maksimov
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 10 (2023)
Aim. To identify predictors of heart failure in patients with dilated cardiomyopathy (DCM) and ischemic myocardial dilatation (IMD).Material and methods. In total, we examined 221 patients with cardiomyopathies: DCM and IMD. The mean age of the patie
Externí odkaz:
https://doaj.org/article/1411da27898442daa033220c976e77df
Autor:
S. Yu. Nikulina, O. O. Kuznetsova, A. A. Chernova, G. V. Matyushin, A. A. Gurazheva, V. N. Maksimov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 4, Pp 564-569 (2021)
Subjects and methods. The study included patients with IDC (group 1; n=111, 89.2% men, average age 51.7±9.7 years) and ICM (group 2; n=110, 91.5% men, average age 58.7±8.4 years). All patients (IDC and ICM) underwent coronary angiography. Based on
Externí odkaz:
https://doaj.org/article/3189415449d54fe1bd073029af34c07b
Autor:
O. D. Ostroumova, A. I. Kochetkov, F. T. Ageev, G. S. Anikin, E. Kh. Akhmetzyanova, E. I. Bezuglova, A. B. Bekoeva, N. Yu. Borovkova, N. G. Vinogradova, E. V. Gorbunova, A. A. Goryacheva, E. S. Zhugrova, O. A. Kislyak, S. M. Klyashev, V. P. Kuzmin, A. A. Lipchenko, G. V. Matyushin, E. A. Mikhailova, V. A. Nevzorova, A. G. Obrezan, T. A. Petrichko, M. M. Petrova, A. N. Reider, A. N. Repin, V. I. Sadovoy, N. P. Sanina, A. E. Skripchenko, R. I. Stryuk, I. V. Faiyance, L. A. Khaisheva, N. R. Khasanov, R. A. Khokhlov, E. E. Tsareva, A. L. Cherkashina, I. I. Shaposhnik, I. A. Shelestova, R. N. Shepel, E. V. Shikh, D. A. Yakhontov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 2, Pp 175-190 (2020)
Aim. To evaluate the effectiveness and safety of telmisartan, used in monotherapy or in combination with hydrochlorothiazide or amlodipine, in real clinical practice in patients with diagnosed arterial hypertension who have not reached the target lev
Externí odkaz:
https://doaj.org/article/9a89b6f41c844d00b164e671e6fe74c3
Autor:
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 3, Pp 335-342 (2019)
Aim. To assess the influence of addition of nicorandil on long-term cardiovascular complications in patients with chronic coronary artery disease (CAD) in the framework of a prospective observational study.Material and methods. Prospective observatio
Externí odkaz:
https://doaj.org/article/95b4520d0f114768bf2f0b8f2b75417f
Autor:
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, L. A. Sokolova, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 3, Pp 408-417 (2018)
Aim. To assess quality of life (QoL) and its dynamics during nicorandil treatment in patients with stable ischemic heart disease, to study the relationship of treatment adherence and QoL indicators when treated with nicorandil.Material and methods. O
Externí odkaz:
https://doaj.org/article/0023968bdeab4c13ae05f5dd324c7dcb
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 3, Pp 324-329 (2018)
The lethality of patients with acute myocardial infarction with ST-segment elevation (STEMI) depends on many factors. In conditions of timely transportation of the patient to the center of percutaneous coronary intervention one of these factors is th
Externí odkaz:
https://doaj.org/article/7d76ce5ac25a4f85a9b8d52d5017a135
Autor:
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Akimova, V. P. Voronina, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, L. A. Sokolova, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 6, Pp 776-786 (2017)
Working Group of the NIKEA Program. Ekaterinburg: Akulina E.N.; Izhevsk: Shinkareva S. E., Grebnev S.A.; Krasnodar: Kudryashov E.A., Fendrikova A.V.; Krasnoyarsk: Nemik D.B., Pitaev R.R., Altaev V.D., Samokhvalov E.V., Stolbikov Y.Y.; Moscow: Dmitrie
Externí odkaz:
https://doaj.org/article/eab6145fb1d4466784e2d93eb5d857f0
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 5, Pp 675-683 (2017)
Assessment of the left atrial (LA) function is important aspect of comprehensive cardiovascular system estimation. Many cardiac diseases make an impact to LA work either by direct affect on myocardium or hemodynamic condition changing. It is consider
Externí odkaz:
https://doaj.org/article/1d50539658a94402be8847d4368e0a7a
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 5, Pp 597-601 (2017)
Background. The discovery of new genetic predictors of cardiovascular diseases can be used in predicting and diagnosing latent forms of the disease. Wolff-Parkinson-White syndrome (WPW) occurs in all age groups and detected in 1-30 people per 10000,
Externí odkaz:
https://doaj.org/article/b194791878d84af4921e93768b5e0ede